Well Referenced

Tag: mistletoe therapy

The Case for Mistletoe in the Treatment of Laryngeal Cancer

This 2014 case report details a 68-year-old patient with aggressive, non-resectable laryngeal carcinoma who achieved complete remission following mistletoe therapy after failing to respond to chemoradiotherapy and salvage laryngectomy. The patient received high-dose intratumoral applications of Viscum album extract (mistletoe), leading to full recovery and hospital discharge. The report underscores

Read More »
June 26, 2025 No Comments

Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients

This retrospective cohort study evaluated the impact of mistletoe extract (Iscador®Qu) as supportive therapy in 324 patients with non-metastatic colorectal cancer (UICC stage I–III) undergoing adjuvant chemo- or radio-chemotherapy. Over a median treatment period of 8.6 months, patients receiving mistletoe therapy (n=181) exhibited a significantly lower incidence of cancer-related fatigue

Read More »
June 26, 2025 No Comments

Intravenous Mistletoe Treatment in Integrative Cancer Care: A Qualitative Study Exploring the Procedures, Concepts, and Observations of Expert Doctors

This 2016 qualitative study explored the use of intravenous mistletoe therapy (MT) in integrative cancer care through interviews with 35 experienced physicians specializing in anthroposophic medicine. The study found that MT is employed to stabilize disease, induce fever, enhance quality of life, and improve the tolerability of conventional treatments. Physicians

Read More »
June 26, 2025 No Comments

Cancer Patients’ Experiences of Using Mistletoe (Viscum album): A Qualitative Systematic Review and Synthesis

This systematic review aimed to synthesize qualitative studies exploring cancer patients’ experiences with mistletoe therapy (MT). A comprehensive search across multiple databases identified 173 papers, of which 17 were reviewed in full, and 14 were excluded. Ultimately, three studies were included in the synthesis. The findings indicated that patients reported

Read More »
June 26, 2025 No Comments

White-Berry Mistletoe (Viscum album L.) as complementary treatment in cancer: Does it help?

White-berry mistletoe (Viscum album L.) has been explored as a complementary cancer therapy, with studies suggesting it may improve response rates, overall survival, and quality of life while reducing side effects from conventional cancer treatments. The extracts, rich in biologically active substances like mistletoe lectins and viscotoxins, have demonstrated immune-stimulating

Read More »
June 26, 2025 No Comments

Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone – efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment

This randomized controlled trial examined the effects of mistletoe extracts as a complementary therapy for breast cancer patients undergoing chemotherapy. The study found that mistletoe therapy significantly improved quality of life by alleviating chemotherapy-related fatigue, enhancing physical and emotional well-being. However, it did not impact cancer progression or survival rates.

Read More »
June 26, 2025 No Comments

Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy in the treatment of stage IV NSCLC patients

This observational study assessed the cost-effectiveness of adding Viscum album L. (mistletoe extract) to standard chemotherapy in patients with stage IV non-small cell lung cancer (NSCLC). Among 118 patients (mean age 63.8, 55.1% male), those receiving Viscum album plus chemotherapy had a longer adjusted mean overall survival (19.1 months) compared

Read More »
June 26, 2025 No Comments

Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review

This systematic review (Forschende Komplementärmedizin, 2009, PMID: 19729932) evaluated 18 clinical trials involving over 6,800 patients to assess the efficacy and safety of standardized mistletoe (Viscum album) preparations as complementary cancer therapy. While the quality of the included studies was generally low and too heterogeneous for meta-analysis, the findings consistently

Read More »
June 26, 2025 No Comments

Evaluation of quality of life in lung cancer patients receiving radiation and Viscum album L.: a real-world data study

This 2023 observational study (Radiation Oncology, PMID: 36879290) evaluated 112 lung cancer patients, primarily with non-small-cell lung cancer (median age 70), to assess the impact of adjunctive Viscum album L. (mistletoe) therapy on quality of life (QoL) during standard treatments, including radiation. Over 12 months, patients receiving radiation plus VA

Read More »
June 26, 2025 No Comments

Fever Therapy With Intravenously Applied Mistletoe Extracts for Cancer Patients: A Retrospective Study

This 2017 retrospective observational study (Integrative Cancer Therapies, PMID: 27387685) investigated the safety and immune-stimulating effects of intravenously applied mistletoe extracts (IAMPs) in 59 cancer patients receiving 567 total infusions. Fever (≥38.5°C) was successfully induced in 76% of patients, with an average temperature increase of 1.5°C. Most adverse events were

Read More »
June 26, 2025 No Comments